Ecthyma gangrenosum in pediatric patients: 10‐year experience at the National Institute of Pediatrics
International Journal of Dermatology · 2023
DOI: 10.1111/ijd.16842 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Constanza García-López und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Intern of the Dirección General de Calidad y Educación en Salud, Secretaría de Salud, Mexico City, Mexico. Hauptthemen laut MEDLINE: Ecthyma, Pseudomonas Infections, Staphylococcal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Ecthyma gangrenosum (EG) usually results from the hematogenous seeding of the skin in the setting of bacteremia, mostly by Pseudomonas aeruginosa , especially in immunocompromised patients. It presents as erythematous‐violaceous macules, or plaques with surrounding erythema before rapidly progressing to bullae and necrotic‐ulcerative eschars.
Methods
We performed a retrospective chart review of EG patients diagnosed at the National Institute of Pediatrics. Data included demographics, underlying disease, cutaneous lesions, location, evolution, microbiologic, histopathologic findings, and treatment. Data were analyzed by descriptive statistics; Mann–Whitney U test and Fisher's exact test were used to evaluate differences between groups.
Results
Seventeen patients with a mean age of 12.5 (6–16) years were included. The most common underlying disease was acute lymphoblastic leukemia (59%), three patients were not immunocompromised (17%). A total of 18 episodes of EG were recorded, 10 (55%) were disseminated at presentation. Systemic manifestations included fever (100%), pain (88.9%), asthenia and adynamia (22.2%). P. aeruginosa was isolated in 10 (55%) cases, followed by Staphylococcus aureus in four. Three patients had sepsis at onset (17%). A comparison between localized versus disseminated, pseudomonal versus nonpseudomonal, and bacteremic versus nonbacteremic EG was performed with no statistical difference between any of the groups, except for longer treatment time for pseudomonal EG, and longer hospitalization days for both pseudomonal EG and bacteremia.
Conclusions
Fever and pain in the setting of rapidly evolving necrotic lesions should prompt the clinical suspicion of EG and the installment of empiric treatment pending culture results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Intern of the Dirección General de Calidad y Educación en Salud, Secretaría de Salud, Mexico City, Mexico.
- Methodology Department, Instituto Nacional de Pediatría, Mexico City, Mexico.
- Dermatology Department, Instituto Nacional de Pediatría, Mexico City, Mexico.
ORCID-Profile: Constanza García-López, Marimar Saez-de-Ocariz
Zitieren
APA
García-López, C., Medina-Vera, I., Orozco-Covarrubias, L., & Saez-de-Ocariz, M. (2023). Ecthyma gangrenosum in pediatric patients: 10‐year experience at the National Institute of Pediatrics. International Journal of Dermatology. https://doi.org/10.1111/ijd.16842
Vancouver
García-López C, Medina-Vera I, Orozco-Covarrubias L, Saez-de-Ocariz M. Ecthyma gangrenosum in pediatric patients: 10‐year experience at the National Institute of Pediatrics. International Journal of Dermatology. 2023. doi:10.1111/ijd.16842
BibTeX
@article{GarcaLpez2023,
author = {García-López, Constanza and Medina-Vera, Isabel and Orozco-Covarrubias, Luz and Saez-de-Ocariz, Marimar},
title = {Ecthyma gangrenosum in pediatric patients: 10‐year experience at the National Institute of Pediatrics},
journal = {International Journal of Dermatology},
year = {2023},
doi = {10.1111/ijd.16842}
}
EUVIMED